melatonin has been researched along with Sterility, Female in 31 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the present study, we aim to evaluate the pregnancy outcomes after the administration of myo-inositol combined with melatonin in women who failed to conceive in previous in vitro fertilization (IVF) cycles due to poor oocyte quality." | 5.15 | Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. ( Buffo, S; Raffone, E; Rizzo, P; Unfer, V, 2011) |
| " The numbers of matured follicles and retrieved oocytes, fertilization rates, implantation rates, clinical pregnancy rate, and intrafollicular concentrations of TNFα, 8-hydroxy-2'-deoxyguanosine (8-OHdG) and hexanoyl-lysine adduct (HEL) as oxidative stress markers, and melatonin and Cu,Zu-superoxide dismutase (Cu,Zn-SOD) as antioxidants were compared between the two groups." | 3.80 | A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis. ( Nakamura, Y; Numa, F; Sugino, N; Takasaki, A; Tamura, H, 2014) |
| "The results showed that thiamine pyrophosphate prevented ischemia/reperfusion injury-related infertility, but melatonin did not provide adequate prevention." | 3.79 | Use of thiamine pyrophosphate to prevent infertility developing in rats undergoing unilateral ovariectomy and with ischemia reperfusion induced in the contralateral ovary. ( Borekci, B; Cetin, N; Gul, MA; Turan, MI; Yapca, OE, 2013) |
| " We present a proposal for a pilot double-blind randomised placebo-controlled dose-response trial aimed to determine whether oral melatonin supplementation during ovarian stimulation can improve the outcomes of assisted reproductive technology." | 2.79 | A pilot double-blind randomised placebo-controlled dose-response trial assessing the effects of melatonin on infertility treatment (MIART): study protocol. ( Fernando, S; Osianlis, T; Rombauts, L; Vollenhoven, B; Wallace, E, 2014) |
| "IVF patients with sleep disorders may benefit from melatonin administration in improving the oocyte and the embryo quality, but the sleeping problem itself may not be fixed." | 2.76 | Melatonin improves the oocyte and the embryo in IVF patients with sleep disturbances, but does not improve the sleeping problems. ( Aksakal, FN; Cicek, N; Devran, A; Eryilmaz, OG; Mollamahmutoğlu, L; Sarikaya, E, 2011) |
| "Melatonin has the potential to be used as a chemotherapeutic adjuvant to simultaneously improve the outcome of anti-cancer treatment and preserve ovarian function during cisplatin chemotherapy." | 1.62 | Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice. ( Chen, G; Chen, J; Guo, E; Huang, J; Li, K; Li, N; Lu, H; Ma, D; Shan, W; Sun, C; Wang, B; Wu, Y; Xi, L; Xia, M; Zhou, B, 2021) |
| "Endometriosis is now considered to be a public health problem that deserves in-depth investigation, especially the etiopathogenesis of endometriosis-associated infertility." | 1.56 | Excessive oxidative stress in cumulus granulosa cells induced cell senescence contributes to endometriosis-associated infertility. ( Dai, Y; Huang, D; Huang, Q; Jin, X; Li, C; Lin, X; Tong, X; Xu, W; Zhang, S; Zhou, F; Zhou, H, 2020) |
| "Melatonin treatment delayed granulosa cell aging progression." | 1.56 | The Immp2l Mutation Causes Ovarian Aging Through ROS-Wnt/β-Catenin-Estrogen Pathway: Preventive Effect of Melatonin. ( Gu, L; He, Q; Li, PA; Lin, Q; Liu, C; Ma, Y; Pei, X; Yang, Y, 2020) |
| "Melatonin levels were found to fluctuate during the menstrual cycle of these subjects with a nadir at mid-cycle and peak occurring at the early follicular/late luteal phases of the cycle (p < 0." | 1.30 | Plasma melatonin profile and hormonal interactions in the menstrual cycles of anovulatory infertile women treated with gonadotropins. ( Chan, TY; Pang, SF; Tang, GW; Tang, PL, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.23) | 18.7374 |
| 1990's | 5 (16.13) | 18.2507 |
| 2000's | 4 (12.90) | 29.6817 |
| 2010's | 11 (35.48) | 24.3611 |
| 2020's | 10 (32.26) | 2.80 |
| Authors | Studies |
|---|---|
| Yuzko, VO | 1 |
| Yuzko, OM | 1 |
| Yuzko, TA | 1 |
| Pryimak, SH | 1 |
| Voloshynovych, NS | 1 |
| Chobaniuk, SI | 1 |
| Aci, R | 1 |
| Ciftci, G | 1 |
| Yigit, S | 1 |
| Sezer, O | 1 |
| Keskin, A | 1 |
| Latif Khan, H | 1 |
| Bhatti, S | 1 |
| Latif Khan, Y | 1 |
| Abbas, S | 1 |
| Munir, Z | 1 |
| Rahman Khan Sherwani, IA | 1 |
| Suhail, S | 1 |
| Hassan, Z | 1 |
| Aydin, HH | 1 |
| Lin, X | 2 |
| Dai, Y | 1 |
| Tong, X | 1 |
| Xu, W | 1 |
| Huang, Q | 1 |
| Jin, X | 1 |
| Li, C | 1 |
| Zhou, F | 1 |
| Zhou, H | 1 |
| Huang, D | 1 |
| Zhang, S | 1 |
| He, Q | 1 |
| Gu, L | 1 |
| Lin, Q | 1 |
| Ma, Y | 1 |
| Liu, C | 1 |
| Pei, X | 1 |
| Li, PA | 1 |
| Yang, Y | 1 |
| Huang, J | 1 |
| Shan, W | 1 |
| Li, N | 2 |
| Zhou, B | 1 |
| Guo, E | 1 |
| Xia, M | 1 |
| Lu, H | 1 |
| Wu, Y | 1 |
| Chen, J | 1 |
| Wang, B | 1 |
| Xi, L | 1 |
| Ma, D | 1 |
| Chen, G | 1 |
| Li, K | 1 |
| Sun, C | 1 |
| Yang, L | 1 |
| Xu, H | 1 |
| Chen, Y | 1 |
| Miao, C | 1 |
| Zhao, Y | 1 |
| Xing, Y | 1 |
| Zhang, Q | 1 |
| Ivanov, D | 1 |
| Mazzoccoli, G | 1 |
| Anderson, G | 1 |
| Linkova, N | 1 |
| Dyatlova, A | 1 |
| Mironova, E | 1 |
| Polyakova, V | 1 |
| Kvetnoy, I | 1 |
| Evsyukova, I | 1 |
| Carbone, A | 1 |
| Nasyrov, R | 1 |
| Hansda, SR | 1 |
| Haldar, C | 1 |
| Jiang, Y | 1 |
| Shi, H | 1 |
| Liu, Y | 1 |
| Zhao, S | 1 |
| Zhao, H | 1 |
| Showell, MG | 1 |
| Mackenzie-Proctor, R | 1 |
| Jordan, V | 1 |
| Hodgson, R | 1 |
| Farquhar, C | 1 |
| Shi, L | 1 |
| Bo, L | 1 |
| Xu, Z | 1 |
| Yapca, OE | 1 |
| Turan, MI | 1 |
| Cetin, N | 1 |
| Borekci, B | 1 |
| Gul, MA | 1 |
| Ermolenko, KS | 2 |
| Rapoport, SI | 2 |
| Solov'eva, AV | 1 |
| Nishihara, T | 1 |
| Hashimoto, S | 1 |
| Ito, K | 1 |
| Nakaoka, Y | 1 |
| Matsumoto, K | 1 |
| Hosoi, Y | 1 |
| Morimoto, Y | 1 |
| Fernando, S | 1 |
| Osianlis, T | 1 |
| Vollenhoven, B | 1 |
| Wallace, E | 1 |
| Rombauts, L | 1 |
| Tamura, H | 3 |
| Takasaki, A | 2 |
| Nakamura, Y | 2 |
| Numa, F | 1 |
| Sugino, N | 2 |
| Pacchiarotti, A | 2 |
| Carlomagno, G | 1 |
| Antonini, G | 1 |
| Radzinsky, VE | 1 |
| Unfer, V | 1 |
| Raffone, E | 1 |
| Rizzo, P | 1 |
| Buffo, S | 1 |
| Eryilmaz, OG | 1 |
| Devran, A | 1 |
| Sarikaya, E | 1 |
| Aksakal, FN | 1 |
| Mollamahmutoğlu, L | 1 |
| Cicek, N | 1 |
| Wójtowicz, M | 1 |
| Jakiel, G | 1 |
| Lovely, LP | 1 |
| Meyer, WR | 1 |
| Ekstrom, RD | 1 |
| Golden, RN | 1 |
| Takayama, H | 1 |
| Kato, H | 1 |
| Miwa, I | 1 |
| Taniguchi, K | 1 |
| Maekawa, R | 1 |
| Asada, H | 1 |
| Taketani, T | 1 |
| Matsuoka, A | 1 |
| Yamagata, Y | 1 |
| Shimamura, K | 1 |
| Morioka, H | 1 |
| Ishikawa, H | 1 |
| Reiter, RJ | 1 |
| Bals-Pratsch, M | 1 |
| De Geyter, C | 1 |
| Müller, T | 1 |
| Frieling, U | 1 |
| Lerchl, A | 1 |
| Pirke, KM | 1 |
| Hanker, JP | 1 |
| Becker-Carus, C | 1 |
| Nieschlag, E | 1 |
| Tang, PL | 1 |
| Chan, TY | 1 |
| Tang, GW | 1 |
| Pang, SF | 1 |
| Partonen, T | 2 |
| Silman, R | 1 |
| Vaughan, MK | 1 |
| O'Steen, WK | 1 |
| Vaughan, GM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of IVF Outcome and Endometrium Effect in Infertility Patients Between Diminished and Normal Ovarian Reserve After Melatonin Administration.[NCT03117725] | 100 participants (Anticipated) | Interventional | 2017-05-12 | Enrolling by invitation | |||
| Myo-inositol for the Management of Poor Ovarian Responders: A Prospective Randomized Controlled Trial[NCT04273256] | Phase 2/Phase 3 | 226 participants (Anticipated) | Interventional | 2020-02-11 | Recruiting | ||
| A Prospective, Randomized, Double Blind, Study on the Clinical Efficacy Myo-inositol Versus D-chiro-inositol in Women Undergoing in Vitro Fertilization Embryo Transfer.[NCT01338844] | Phase 4 | 0 participants | Interventional | Completed | |||
| Sleep Length and Euploid Embryo Transfer Prospective Study[NCT06139757] | 150 participants (Anticipated) | Observational | 2024-01-01 | Not yet recruiting | |||
| The Potential Effects of Inofolic Plus on Abnormal Ovarian Reserve Parameters in Subfertile Women[NCT01290432] | 15 participants (Actual) | Interventional | 2011-02-28 | Completed | |||
| Effects of Myo-inositol Plus Melatonin in Perimenopausal Women[NCT01325389] | 0 participants | Interventional | Recruiting | ||||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for melatonin and Sterility, Female
| Article | Year |
|---|---|
Melatonin, Its Beneficial Effects on Embryogenesis from Mitigating Oxidative Stress to Regulating Gene Expression.
Topics: Animals; Embryo Implantation; Embryo, Mammalian; Embryonic Development; Female; Gene Expression Regu | 2021 |
Applications of Melatonin in Female Reproduction in the Context of Oxidative Stress.
Topics: Animals; Female; Humans; Infertility, Female; Melatonin; Oxidative Stress; Polycystic Ovary Syndrome | 2021 |
Inositol for subfertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Administration, Oral; Birth Rate; Clomiphene; Combined Modality Therapy; Fema | 2018 |
Melatonin and hypothalamic-pituitary-gonadal axis.
Topics: Animals; Circadian Rhythm; Female; Gonads; Humans; Hypothalamus; Infertility, Female; Melatonin; Oxi | 2013 |
[STATE-OF-THE-ART OF REALIZATION OF THE FERTILITY POTENTIAL IN THE WOMEN OF LATE REPRODUCTIVE AGE].
Topics: Age Factors; Female; Fertility; Fertilization in Vitro; Humans; Infertility, Female; Melatonin; Repr | 2016 |
[Melatonin and its role in human reproduction].
Topics: Adult; Circadian Rhythm; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Human | 2002 |
Melatonin and the human gonadotrophin-releasing hormone pulse generator.
Topics: Circadian Rhythm; Contraception; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female | 1991 |
6 trials available for melatonin and Sterility, Female
| Article | Year |
|---|---|
Oral melatonin supplementation improves oocyte and embryo quality in women undergoing in vitro fertilization-embryo transfer.
Topics: Administration, Oral; Adult; Female; Fertilization in Vitro; Humans; Infertility, Female; Male; Mela | 2014 |
A pilot double-blind randomised placebo-controlled dose-response trial assessing the effects of melatonin on infertility treatment (MIART): study protocol.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Antioxidants; Deoxyguanosine; Dietary Supplements; Double-Blind Method; | 2014 |
Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome.
Topics: Adult; Antioxidants; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Embryo Tra | 2016 |
Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study.
Topics: Adult; Cohort Studies; Female; Fertilization in Vitro; Follicle Stimulating Hormone, Human; Humans; | 2011 |
Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study.
Topics: Adult; Cohort Studies; Female; Fertilization in Vitro; Follicle Stimulating Hormone, Human; Humans; | 2011 |
Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study.
Topics: Adult; Cohort Studies; Female; Fertilization in Vitro; Follicle Stimulating Hormone, Human; Humans; | 2011 |
Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study.
Topics: Adult; Cohort Studies; Female; Fertilization in Vitro; Follicle Stimulating Hormone, Human; Humans; | 2011 |
Melatonin improves the oocyte and the embryo in IVF patients with sleep disturbances, but does not improve the sleeping problems.
Topics: Central Nervous System Depressants; Embryo Transfer; Embryo, Mammalian; Female; Fertilization in Vit | 2011 |
Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Deoxyguanosine; Female; Fertilization in Vitro; | 2008 |
Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Deoxyguanosine; Female; Fertilization in Vitro; | 2008 |
Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Deoxyguanosine; Female; Fertilization in Vitro; | 2008 |
Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Deoxyguanosine; Female; Fertilization in Vitro; | 2008 |
18 other studies available for melatonin and Sterility, Female
| Article | Year |
|---|---|
Comparative characteristics of infertile women when applying melatonin in complex preparation for assisted reproductive technologies.
Topics: Anti-Mullerian Hormone; Estradiol; Female; Follicle Stimulating Hormone; Humans; Infertility, Female | 2022 |
Clock 3111 T/C and Period3 VNTR gene polymorphisms and proteins, and melatonin levels in women with infertility.
Topics: CLOCK Proteins; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Infertility | 2023 |
Cell-free nucleic acids and melatonin levels in human follicular fluid predict embryo quality in patients undergoing in-vitro fertilization treatment.
Topics: Adult; Cell-Free Nucleic Acids; Chorionic Gonadotropin; DNA; DNA Copy Number Variations; DNA Fragmen | 2020 |
Excessive oxidative stress in cumulus granulosa cells induced cell senescence contributes to endometriosis-associated infertility.
Topics: Animals; Antigens, Neoplasm; Cell Line; Cellular Senescence; Cumulus Cells; Disease Models, Animal; | 2020 |
The Immp2l Mutation Causes Ovarian Aging Through ROS-Wnt/β-Catenin-Estrogen Pathway: Preventive Effect of Melatonin.
Topics: Animals; Antioxidants; beta Catenin; Cells, Cultured; Cellular Senescence; Endopeptidases; Estrogens | 2020 |
Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice.
Topics: Animals; Animals, Newborn; Antineoplastic Agents; Antioxidants; Cisplatin; Drug Evaluation, Preclini | 2021 |
Melatonin: Multi-Target Mechanism Against Diminished Ovarian Reserve Based on Network Pharmacology.
Topics: Apoptosis; Cell Proliferation; Computational Biology; Databases, Protein; Endocrine System; Female; | 2021 |
Uterine anomalies in cell proliferation, energy homeostasis and oxidative stress in PCOS hamsters, M. auratus: Therapeutic potentials of melatonin.
Topics: Animals; Aromatase Inhibitors; Blood Glucose; Cell Proliferation; Cricetinae; Disease Models, Animal | 2021 |
Use of thiamine pyrophosphate to prevent infertility developing in rats undergoing unilateral ovariectomy and with ischemia reperfusion induced in the contralateral ovary.
Topics: Animals; Antioxidants; Disease Models, Animal; Female; Infertility, Female; Melatonin; Ovarian Disea | 2013 |
[Melatonin secretion in women of advanced reproductive age].
Topics: Adult; Age Factors; Female; Humans; Infertility, Female; Melatonin | 2013 |
A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Biomarkers; Deoxyguanosine; Endometriosis; Female; Fertilization | 2014 |
Effect of stress on pregnancy outcome among women undergoing assisted reproduction procedures.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Female; Humans; Hydrocortisone; Infertility, Female; Me | 2003 |
Increased endogenous level of melatonin in preovulatory human follicles does not directly influence progesterone production.
Topics: Cells, Cultured; Estradiol; Female; Follicular Fluid; Follicular Phase; Humans; Infertility, Female; | 2003 |
Episodic variations of prolactin, thyroid-stimulating hormone, luteinizing hormone, melatonin and cortisol in infertile women with subclinical hypothyroidism.
Topics: Adult; Circadian Rhythm; Dehydroepiandrosterone Sulfate; Estradiol; Female; Humans; Hydrocortisone; | 1997 |
Plasma melatonin profile and hormonal interactions in the menstrual cycles of anovulatory infertile women treated with gonadotropins.
Topics: Adult; Anovulation; Chorionic Gonadotropin; Estradiol; Female; Follicle Stimulating Hormone; Follicu | 1998 |
Melatonin-dependent infertility.
Topics: Animals; Circadian Rhythm; Female; Fertility; Humans; Infertility, Female; Infertility, Male; Light; | 1999 |
Short note: melatonin-dependent infertility.
Topics: Female; Humans; Infertility, Female; Infertility, Male; Light; Male; Melatonin; Models, Biological; | 1999 |
Estrous cycle changes after prenatal and neonatal injections of melatonin in normal and androgen-sterilized female rats.
Topics: Animals; Animals, Newborn; Estrus; Female; Hypothalamus; Infertility, Female; Melatonin; Ovulation; | 1970 |